Expression of ANXA13 in cancer - Staining overview

The cancer tissue page shows antibody staining in 20 different cancers. The overall cancer tissue staining statistics shows the fraction of patient samples with high, medium, low or not detected (as described by the color-coding scale in the box to the right), using all the available antibodies to the protein targets encoded by this gene. The assay and annotation is described here.

The cancers can be ordered histologically or alphabetically.

For each cancer, the staining for each available antibody is reported as the fraction of samples with antibody staining level high, medium, low or not detected (as described by the color-coding scale in the box to the right). The length of the bar represents the number of patient samples analyzed (max=12 patients). By clicking on a cancer tissue, the detailed staining data for that cancer is available, including annotated images.

At the bottom of this page, a summary for the cancer staining for each antibody is given, together with the literature conformity for the staining pattern revealed by that specific antibody.

Antibody HPA018535

Antibody HPA019569

Antibody HPA019650

Antibody CAB025135

Tissue

Antibody staining

Summary

Several breast, pancreatic, renal, testicular, thyroid and skin cancers exhibited weak to moderate cytoplasmic positivity with additional/or nuclear/membranous staining in few cases. Remaining cancer tissues were weakly stained or negative.

Most cancer tissues were negative. Hepatocellular carcinomas displayed moderate to strong cytoplasmic positivity.

A single case each of pancreas and renal cancers displayed strong membranous and cytoplasmic staining. Renal cell carcinomas along with several pancreas, few stomach and liver cancers showed weak to moderate positivity. Other cancer tissues were weakly stained or negative.

Colorectal and liver cancers showed moderate to strong cytoplasmic staining while moderate cytoplasmic immunoreactivity was observed in a majority of renal cancers as well as several gastric, endometrial, testis and pancreatic cancers. Remaining cancer cells were weakly stained or negative.

Literature conformity

Consistent with extensive gene/protein characterization data

Partly consistent with extensive gene/protein characterization data

Consistent with extensive gene/protein characterization data

Partly consistent with extensive gene/protein characterization data

Level of antibody staining/expression

High
Medium
Low
Not detected

The Human Protein Atlas project is funded by the Knut & Alice Wallenberg foundation.